Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPSAB1 | Q15661 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.45 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.45 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23879899 | 0.90 | KMT2A (0.59) | TPSAB1LMNAGAAMEN1KMT2A | |
| SCHEMBL16384737 | 0.90 | TPSAB1 (0.49) | TPSAB1LMNAGAAMEN1KMT2A | |
| SCHEMBL1299177 | 0.88 | GAA (0.53) | TPSAB1LMNAGAAMEN1KMT2A | |
| SCHEMBL21422726 | 0.86 | TPSAB1 (0.46) | TPSAB1LMNAGAAMEN1KMT2A | |
| SCHEMBL17803834 | 0.86 | TPSAB1 (0.46) | TPSAB1LMNAGAAMEN1KMT2A | |
| SCHEMBL21301043 | 0.85 | MEN1 (0.48) | TPSAB1LMNAGAAMEN1KMT2A | |
| SCHEMBL15748044 | 0.85 | CYP3A4 (0.55) | TPSAB1GAAMEN1KMT2AHDAC3 | |
| SCHEMBL21422711 | 0.83 | TPSAB1 (0.43) | TPSAB1LMNAGAAMEN1KMT2A | |
| SCHEMBL21301045 | 0.83 | TPSAB1 (0.44) | TPSAB1LMNAGAAMEN1KMT2A | |
| SCHEMBL14677758 | 0.82 | HTT (0.57) | TPSAB1LMNAGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11738100-B2 | Formulations and kits for radiotherapy and diagnostic imaging | Clarity Pharmaceuticals Limited (AU) | 2023-08-29 | — | — | US | disclosed |
| US-11738100-B2 | Formulations and kits for radiotherapy and diagnostic imaging | Clarity Pharmaceuticals Limited (AU) | 2023-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11738100-B2 | Formulations and kits for radiotherapy and diagnostic imaging | FOLH1, GGH, CD74 | TPSAB1 301/4885LMNA 3672/4885GAA 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.